Starling Oncology, Inc. (STLN)
3.50
-0.25
(-6.67%)
USD |
NASDAQ |
Nov 13, 16:00
3.48
-0.02
(-0.57%)
After-Hours: 19:59
Starling Oncology Enterprise Value : 422.80M for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 422.80M |
| November 12, 2026 | 448.30M |
| November 11, 2026 | 494.20M |
| November 10, 2026 | 508.48M |
| November 09, 2026 | 473.80M |
| November 06, 2026 | 435.04M |
| November 05, 2026 | 749.17M |
| November 04, 2026 | 773.65M |
| November 03, 2026 | 712.46M |
| November 02, 2026 | 703.28M |
| October 30, 2026 | 731.84M |
| October 29, 2026 | 744.08M |
| October 28, 2026 | 743.06M |
| October 27, 2026 | 737.96M |
| October 26, 2026 | 707.36M |
| October 23, 2026 | 750.19M |
| October 22, 2026 | 770.59M |
| October 21, 2026 | 762.43M |
| October 20, 2026 | 742.04M |
| October 19, 2026 | 724.70M |
| October 16, 2026 | 721.64M |
| October 15, 2026 | 770.59M |
| October 14, 2026 | 729.80M |
| October 13, 2026 | 749.17M |
| October 12, 2026 | 771.61M |
| Date | Value |
|---|---|
| October 09, 2026 | 742.04M |
| October 08, 2026 | 696.14M |
| October 07, 2026 | 721.64M |
| October 06, 2026 | 736.94M |
| October 05, 2026 | 708.38M |
| October 02, 2026 | 713.48M |
| October 01, 2026 | 699.71M |
| September 30, 2026 | 710.42M |
| September 29, 2026 | 717.44M |
| September 28, 2026 | 730.50M |
| September 25, 2026 | 732.51M |
| September 24, 2026 | 717.44M |
| September 23, 2026 | 748.58M |
| September 22, 2026 | 771.69M |
| September 21, 2026 | 749.59M |
| September 18, 2026 | 762.65M |
| September 17, 2026 | 729.49M |
| September 16, 2026 | 719.44M |
| September 15, 2026 | 703.37M |
| September 14, 2026 | 718.44M |
| September 11, 2026 | 683.28M |
| September 10, 2026 | 686.29M |
| September 09, 2026 | 695.33M |
| September 08, 2026 | 698.35M |
| September 04, 2026 | 659.16M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Astrana Health, Inc. | 1.922B |
| Agilon Health, Inc. | 1.664B |
| Nakamoto, Inc. | 237.18M |
| American Oncology Network, Inc. | -- |
| Regional Health Properties, Inc. | 59.99M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -13.29M |
| Revenue (Quarterly) | 169.77M |
| Total Expenses (Quarterly) | 183.06M |
| EPS Diluted (Quarterly) | -0.1269 |
| Gross Profit Margin (Quarterly) | 17.17% |
| Profit Margin (Quarterly) | -7.83% |
| Earnings Yield | -8.31% |
| Normalized Earnings Yield | -6.54 |